IMVIQ
Price:
$0.00001
Market Cap:
$117.00
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunov...[Read more]
Industry
Biotechnology
IPO Date
2009-10-09
Stock Exchange
PNK
Ticker
IMVIQ
According to IMV Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 117.00. This represents a change of -100.00% compared to the average of 7.73M of the last 4 quarters.
The mean historical Enterprise Value of IMV Inc. over the last ten years is 105.88M. The current 117.00 Enterprise Value has changed -99.99% with respect to the historical average. Over the past ten years (40 quarters), IMVIQ's Enterprise Value was at its highest in in the September 2020 quarter at 357.30M. The Enterprise Value was at its lowest in in the December 2020 quarter at -28370558.00.
Average
105.88M
Median
63.71M
Minimum
-28370558.00
Maximum
304.85M
Discovering the peaks and valleys of IMV Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.80%
Maximum Annual Enterprise Value = 304.85M
Minimum Annual Increase = -352.23%
Minimum Annual Enterprise Value = -28370558.00
Year | Enterprise Value | Change |
---|---|---|
2022 | 27.95M | -60.94% |
2021 | 71.56M | -352.23% |
2020 | -28370558.00 | -115.46% |
2019 | 183.55M | -39.79% |
2018 | 304.85M | 4.18% |
2017 | 292.63M | 367.80% |
2016 | 62.55M | -3.55% |
2015 | 64.86M | 23.01% |
2014 | 52.73M | 99.00% |
2013 | 26.50M | 6.68% |
The current Enterprise Value of IMV Inc. (IMVIQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
23.71M
5-year avg
111.91M
10-year avg
105.88M
IMV Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IMV Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IMV Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is IMV Inc.'s Enterprise Value?
What is the highest Enterprise Value for IMV Inc. (IMVIQ)?
What is the 3-year average Enterprise Value for IMV Inc. (IMVIQ)?
What is the 5-year average Enterprise Value for IMV Inc. (IMVIQ)?
How does the current Enterprise Value for IMV Inc. (IMVIQ) compare to its historical average?